Bristol Myers Snaps Up MyoKardia For $225/Share
Bristol Myers Squibb (BMY) has agreed to acquire MyoKardia Inc. (MYOK) for $13.1 billion, or $225.00 per share in cash.
Full Article
Bristol Myers Snaps Up MyoKardia For $225/Share
RTTNews
0 shares
1 views
You might like
Related news coverage
Bristol Myers to acquire MyoKardia for £10 billion
Invezz
In an announcement on Monday, Bristol Myers Squibb Co (NYSE: BMY) said it will invest £10 billion to acquire MyoKardia Inc..
-
US stocks rebound as investors bet on renewed hopes for stimulus deal
Proactive Investors
-
US stocks higher and FTSE 100 closes up as sentiment is boosted on US stimulus package hopes
Proactive Investors
-
Stock Alert: MyoKardia Surges 60% On Bristol Myers Acquisition
RTTNews
-
US benchmarks race out of the blocks Monday on reports of President Trump's health and stimulus package hopes
Proactive Investors
Advertisement
More coverage
UPDATED: Bristol Myers offers a big premium to reel in Myokardia's cardio pipeline with a $13B buyout
Five months after MyoKardia $MYOK swept its late-stage pivotal on its lead heart drug — highlighting its success with a precision..
Upworthy